Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hematologic Neoplasms × ulixertinib × Clear all

Sponsor

Conditions

Wilms Tumor 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Xanthogranuloma, Juvenile 1 Uveal Melanoma 1 Pancreatic Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Histiocytic Sarcoma 1 Gastrointestinal Neoplasms 1 Central Nervous System Neoplasms 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1

Interventions

Cyclophosphamide 34 fludarabine 25 fludarabine phosphate 24 Tacrolimus 24 Mycophenolic Acid 23 Whole-Body Irradiation 22 Busulfan 15 Methotrexate 12 Melphalan 12 Granulocyte Colony-Stimulating Factor 12 Antilymphocyte Serum 12 thymoglobulin 11 Cyclosporine 11 Stem Cell Transplantation 10 Filgrastim 10 Rituximab 9 Thiotepa 7 Peripheral Blood Stem Cell Transplantation 7 Nivolumab 7 Dexamethasone 7 Radiotherapy 6 Mesna 6 Cytarabine 6 trametinib 5 Prednisone 5 Calcium Dobesilate 5 Bortezomib 5 Azacitidine 5 Alemtuzumab 5 Voriconazole 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡